Zero Relapses in Patients With NMOSD Given Ravulizumab

  Sean J. Pittock, MD, Director of Mayo Clinic’s Center for Multiple Sclerosis and Autoimmune Neurology and of Mayo’s Neuroimmunology Laboratory discusses the latest results from Phase III CHAMPION-NMOSD trial recently presented at European Committee...

Dravet Syndrome Clinical Trial With STK-001 Continues

  Barry S. Ticho, MD, PhD, Chief Medical Officer at Stoke Therapeutics, discusses the phase 1/2a MONARCH study, which is evaluating STK-001 in patients with Dravet syndrome. As Dr. Ticho explains, Dravet syndrome is a rare neurological condition that usually...

Treating Phelan-McDermid Syndrome (PMS) Is Complicated

  Alex Kolevzon, MD, Professor of Psychiatry and Pediatrics at the Icahn School of Medicine at Mount Sinai, explains the pathophysiology of Phelan-McDermid syndrome and how it is current treated. Phelan-McDermid syndrome is genetic disorder and one of few known...